Biology Driven Targeted Therapy of Pediatric Soft-Tissue and Bone Tumors: Current Opportunities and Future Challenges

dc.creatorGrunewald, Thomas G. P.
dc.creatorFulda, Simone
dc.date.accessioned2020-10-06T16:12:04Z
dc.date.accessioned2022-09-23T18:46:09Z
dc.date.available2020-10-06T16:12:04Z
dc.date.available2022-09-23T18:46:09Z
dc.date.created2020-10-06T16:12:04Z
dc.identifier978-2-889-19819-1
dc.identifier1664-8714
dc.identifierhttps://www.frontiersin.org/research-topics/3276/biology-driven-targeted-therapy-of-pediatric-soft-tissue-and-bone-tumors-current-opportunities-and-f#nogo
dc.identifierhttp://hdl.handle.net/20.500.12010/14246
dc.identifier10.3389/978-2-88919-819-1
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3507058
dc.languageeng
dc.publisherFrontiers Media SA
dc.relationGrünewald, T. G. P., Fulda, S., eds. (2016). Biology-Driven Targeted Therapy of Pediatric Soft-Tissue and Bone Tumors: Current Opportunities and Future Challenges. Lausanne: Frontiers Media. doi: 10.3389/978-2-88919-819-1
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.rightshttps://creativecommons.org/licenses/by/4.0/
dc.subjectOncology
dc.subjectMedicine (General)
dc.subjectSarcoma
dc.subjectPediatric oncology
dc.titleBiology Driven Targeted Therapy of Pediatric Soft-Tissue and Bone Tumors: Current Opportunities and Future Challenges


Este ítem pertenece a la siguiente institución